Article Text

PDF
SP0134 Refractory rheumatoid arthritis; all the therapeutic arrows spent?
  1. A.P. Malaviya
  1. Rheumatology, Addenbrooke’s University Hospital Nhs Trust, Cambridge, United Kingdom

Abstract

45 year old female patient.

Severe active refractory seropositive erosive rheumatoid arthritis.

Failed treatment with the following conventional DMARDs:

1. Methotrexate

2. Leflunamide

3. Sulphasalazine

4. Myocrisin

5. Cyclosporin

6. Cyclophosphamide

7. Azathioprine

8. Mycophenolate

Failed treatment with the following biologic DMARDs:

1. Infliximab

2. Etanercept

3. Adalimumab

4. Rituximab

5. Abatacept

6. Tocilizumab

Disclosure of Interest None Declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.